2020 Neuroblastoma (pilot)

Scheme description
-
Disorders/Gene target(s)
Neuroblastoma
Clinical cases
One
Testing/analysis
Recurrent copy number and structural rearrangements
Sample type
Online
Techniques
Any methodology
Assessment
Submit a clinical report to include:
• Analysis of results
• Interpretation of the result
• Clerical accuracy
As this is a pilot EQA no performance criteria are applied
Eligibility
All laboratories worldwide
Languages
English ONLY
ISO17043 Accredited EQA
No
EQA timeline
Sample dispatchSeptember 2020
Testing period5 weeks
Assessment resultsDecember 2020
Final Summary reportNot applicable
Other information
Fee
£260.00
GenQA code
2020NEUROB
« Return to EQA scheme list
Go to top